The Commission on Cancer (CoC), a program of the American College of Surgeons (ACoS), has granted Three-Year Accreditation to the cancer program at PSJMC. To earn voluntary CoC accreditation, our cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in their commitment and delivery of comprehensive, high-quality, and multidisciplinary patient-centered care.
As a CoC-accredited Cancer Center, PSJMC takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary partnership results in improved patient care.
“Achieving CoC accreditation is a reflection of the hard work, dedication and collaboration of the multidisciplinary team who strive for the highest quality of care and best outcomes within our cancer program,” says Sue Krueger, Director, Ancillary Services. The CoC Accreditation Program provides the framework for PSJMC to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease, and end-of- life care. When patients receive care at PSJMC, they also have access to information on clinical trials and new treatments, genetic counseling, and patient centered services including psycho-social support, a patient navigation process, and survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life.
Like all CoC-accredited facilities, PSJMC maintains a cancer registry and contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society (ACS). This nationwide oncology outcomes database is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care. PSJMC, in turn, has access to information derived from this type of data analysis, which is used to create national, regional, and state benchmark reports. These reports help in our continuous quality improvement efforts. PSJMC is dedicated to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive quality care. There are currently 1,500 CoC-accredited cancer programs in the U.S., representing 30 percent of all hospitals. CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed cancer patients.